Jeremy Manry
Gif-sur-yvette, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Journal: Genome medicine
Published: January 06, 2024
Transcriptome immune-regulatory differences between leprosy patients and type 1 reaction patients, before onset of symptoms.
Journal: PLoS neglected tropical diseases
Published: December 15, 2023
Allele-dependent interaction of LRRK2 and NOD2 in leprosy.
Journal: PLoS pathogens
Published: December 14, 2022
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Journal: medRxiv : the preprint server for health sciences
Published: November 03, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.
Journal: Science immunology
Published: July 20, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 16, 2022
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria.
Journal: Cell
Published: April 01, 2022
Autoantibodies against type I IFNs in patients with critical influenza pneumonia.
Journal: The Journal of experimental medicine
Published: March 22, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies.
Journal: Research square
Published: January 19, 2022
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
Journal: Science immunology
Published: July 13, 2021
Last Updated: 09/26/2026